209 related articles for article (PubMed ID: 32344890)
21. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
[TBL] [Abstract][Full Text] [Related]
22. Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model.
Platteel ACM; Nieuwenhuizen NE; Domaszewska T; Schürer S; Zedler U; Brinkmann V; Sijts AJAM; Kaufmann SHE
Front Immunol; 2017; 8():1744. PubMed ID: 29312295
[TBL] [Abstract][Full Text] [Related]
23. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
24. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
[TBL] [Abstract][Full Text] [Related]
25. Variable BCG efficacy in rhesus populations: Pulmonary BCG provides protection where standard intra-dermal vaccination fails.
Verreck FAW; Tchilian EZ; Vervenne RAW; Sombroek CC; Kondova I; Eissen OA; Sommandas V; van der Werff NM; Verschoor E; Braskamp G; Bakker J; Langermans JAM; Heidt PJ; Ottenhoff THM; van Kralingen KW; Thomas AW; Beverley PCL; Kocken CHM
Tuberculosis (Edinb); 2017 May; 104():46-57. PubMed ID: 28454649
[TBL] [Abstract][Full Text] [Related]
26. Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination.
Kurtz SL; Mittereder LR; Lehman CC; Khan H; Gould VA; Elkins KL
Infect Immun; 2023 Jul; 91(7):e0016823. PubMed ID: 37338410
[TBL] [Abstract][Full Text] [Related]
27. Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen.
Bruffaerts N; Pedersen LE; Vandermeulen G; Préat V; Stockhofe-Zurwieden N; Huygen K; Romano M
PLoS One; 2015; 10(7):e0132288. PubMed ID: 26172261
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and Protection against
Arrieta-Villegas C; Vidal E; Martín M; Verdés J; Moll X; Espada Y; Singh M; Villarreal-Ramos B; Domingo M; Pérez de Val B
Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33322064
[TBL] [Abstract][Full Text] [Related]
29. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guérin vaccinated and nonvaccinated cattle.
Hope JC; Kwong LS; Sopp P; Collins RA; Howard CJ
Scand J Immunol; 2000 Sep; 52(3):285-91. PubMed ID: 10972905
[TBL] [Abstract][Full Text] [Related]
31. Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of Mycobacterium tuberculosis.
Counoupas C; Pinto R; Nagalingam G; Britton WJ; Triccas JA
Vaccine; 2018 May; 36(19):2619-2629. PubMed ID: 29627232
[TBL] [Abstract][Full Text] [Related]
32. Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing.
Sharpe SA; McShane H; Dennis MJ; Basaraba RJ; Gleeson F; Hall G; McIntyre A; Gooch K; Clark S; Beveridge NE; Nuth E; White A; Marriott A; Dowall S; Hill AV; Williams A; Marsh PD
Clin Vaccine Immunol; 2010 Aug; 17(8):1170-82. PubMed ID: 20534795
[TBL] [Abstract][Full Text] [Related]
33. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
34. Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans.
Jeyanathan M; Fritz DK; Afkhami S; Aguirre E; Howie KJ; Zganiacz A; Dvorkin-Gheva A; Thompson MR; Silver RF; Cusack RP; Lichty BD; O'Byrne PM; Kolb M; Medina MFC; Dolovich MB; Satia I; Gauvreau GM; Xing Z; Smaill F
JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34990408
[TBL] [Abstract][Full Text] [Related]
35. Induction of mycobacterial protective immunity by sublingual BCG vaccination.
Eickhoff CS; Blazevic A; Killoran EA; Morris MS; Hoft DF
Vaccine; 2019 Aug; 37(36):5364-5370. PubMed ID: 31331776
[TBL] [Abstract][Full Text] [Related]
36. Prevention of tuberculosis in macaques after intravenous BCG immunization.
Darrah PA; Zeppa JJ; Maiello P; Hackney JA; Wadsworth MH; Hughes TK; Pokkali S; Swanson PA; Grant NL; Rodgers MA; Kamath M; Causgrove CM; Laddy DJ; Bonavia A; Casimiro D; Lin PL; Klein E; White AG; Scanga CA; Shalek AK; Roederer M; Flynn JL; Seder RA
Nature; 2020 Jan; 577(7788):95-102. PubMed ID: 31894150
[TBL] [Abstract][Full Text] [Related]
37. Aerosol immunization by alginate coated mycobacterium (BCG/MIP) particles provide enhanced immune response and protective efficacy than aerosol of plain mycobacterium against M.tb. H37Rv infection in mice.
Nagpal PS; Kesarwani A; Sahu P; Upadhyay P
BMC Infect Dis; 2019 Jul; 19(1):568. PubMed ID: 31262260
[TBL] [Abstract][Full Text] [Related]
38. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV
J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255
[TBL] [Abstract][Full Text] [Related]
39. BCG vaccination in India and tuberculosis in children: newer facets.
Udani PM
Indian J Pediatr; 1994; 61(5):451-62. PubMed ID: 7744445
[TBL] [Abstract][Full Text] [Related]
40. Impact of SIV infection on mycobacterial lipid-reactive T cell responses in Bacillus Calmette-Guérin (BCG) inoculated macaques.
Walker EM; Merino KM; Slisarenko N; Grasperge BF; Mehra S; Roy CJ; Kaushal D; Rout N
Front Immunol; 2022; 13():1085786. PubMed ID: 36726992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
